Thursday, September 24, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 19, 2026

The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond

View original at nasdaq.com
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond Key Points AbbVie provides an attractive combination of income, value, and growth…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • AbbVie should deliver solid growth over the next few years driven by drugs like Rinvoq and Skyrizi and promising late-stage pipeline programs

    60% confidence

  • Now is a great time to invest in dividend stocks with above-average yields

    60% confidence

  • Realty Income has particularly promising opportunities in Europe, where the total addressable market is $8.5 trillion and competition is limited

    60% confidence

  • The Federal Reserve is virtually paralyzed by uncertainty about inflation and the job market

    60% confidence

  • Enbridge expects to deliver growth across all aspects of its business, especially in natural gas transmission

    60% confidence

  • The 10 stocks identified by Stock Advisor could produce monster returns in the coming years

    60% confidence

  • Enbridge has visible growth through the end of the decade, with roughly $50 billion of opportunities identified

    60% confidence

Data points we hold from this source

S&P 500 · healthcare sector forward pe ratio17.4 ratio
S&P 500 · forward pe ratio20 ratio
AbbVie Inc. · dividend increase streak53 years
AbbVie Inc. · forward pe ratio14.3 ratio
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Go Mainstream, But Trustworthy Data Access Lags Adoption
A wave of enterprise AI agent activity — fresh funding (Latitude's $35M Series A), a run of CB Insights CEO interviews spotlighting fintech- and healthcare-focused agent startups (Covecta, Penguin AI, Maisa AI), and major platform partnerships (Microsoft-Mistral, Manulife-Microsoft AI governance, Siemens-NVIDIA agentic EDA, Box's agent security controls) — signals agentic AI moving from pilot to production across financial and enterprise workflows. Yet Google Cloud's own research shows adoption is outrunning data readiness (companies average AI access to only 45% of their data, with 'data laggards' capped near 30%), while insider selling at incumbent C3.ai hints at mixed investor conviction even as the broader ecosystem accelerates.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,305 source documents archived
Query this data → isubstrate.com
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond — Source | Via News | Via News